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Andreas Baranyi1*, Till Krauseneck2 and Hans-Bernd Rothenhäusler1,2Abstract
Background: Solid-organ transplantations (SOT) are usually life-saving high-tech medical procedures. The
transplantation itself and the intensive care unit stay could be traumatic stressors triggering posttraumatic stress
symptoms (PTSS). Our retrospective follow-up study aimed to explore preoperative risk factors of PTSS in a cohort of SOT
recipients, and we investigated how PTSS are associated with health-related quality of life (HRQOL) and life satisfaction.
Methods: 126 SOT recipients were enrolled in this investigation. Psychiatric examination of all SOT candidates based on
the Transplant Evaluation Rating Scale was carried out before SOT, and after SOT, recipients completed the PTSS-10, the
SF-36 and the FLZ.
Results: After the surgical intervention 19 (15.1%) SOT recipients had clinical significant PTSS. Preoperative risk factors for
developing postoperative PTSS were: 1.) preexisting psychiatric morbidity, 2.) history of retransplantation, 3.) chronic
benzodiazepine consumption, 4.) age, and 5.) type of transplantation.
SOT-related PTSS were associated with maximal decrements in HRQOL and life satisfaction. The following HRQOL and
life satisfaction domains were affected: Physical Functioning, Role Physical, Pain, General Health, Vitality, Social
Functioning, Role Emotional, Mental Health, Occupation/Work and Character/Own Skills.
Conclusion: SOT recipients may face a major risk of transplantation- and treatment-related PTSS and the development
of impairments to HRQOL and life satisfaction.
Keywords: Solid-organ transplantation, Intensive care unit, Posttraumatic stress symptoms, Preoperative risk factors,
Health-related quality of life, Life satisfactionBackground
Great advances have been made in the field of trans-
plantation surgery, and the success of solid-organ trans-
plantations (SOTs) is no longer measured solely by their
effect on physical morbidity and mortality but also by
their impact on transplant recipients’ mental health and
wellbeing [1-12].
It needs to be mentioned that for those directly affected,
SOTs are usually life-saving but nevertheless stressful and
serious interventions associated with the risk of numerous* Correspondence: Andreas.Baranyi@klinikum-graz.at
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reproduction in any medium, provided the ormedical complications (e.g. acute rejection, infections,
bleeding). It is therefore not surprising that psychiatric
morbidity (e.g. delirium, affective disorders, anxiety disor-
ders and adjustment disorders) is a frequent finding in
patients after SOT. The available frequency data for psychi-
atric morbidity after liver transplantation range from 54% 3
months after transplantation to 22% in a 3.8 years follow-
up. Observed rates for anxiety disorders (e.g. panic disorder,
generalized anxiety disorder, and posttraumatic stress dis-
order related to the transplant experiences) in transplant
populations range from 3% to 33% in the first years after
transplantation [13-16]. The pretransplant evaluation- and
waiting period result in stress and uncertainty in SOT-
candidates [17,18]. Furthermore, the transplantation itselfLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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stressors that can trigger posttraumatic stress symptoms
(PTSS) [1].
Health-related quality of life (HRQOL) and life satisfac-
tion are now an important measure of outcome in SOT
recipients [18-22]. Collis et al. [23] and Rothenhäusler
et al. [24] demonstrated that there is a significant associ-
ation between impaired HRQOL and psychiatric morbid-
ity in patients after liver transplantation.
Research questions
Knowledge about possible predictors and risk factors of
posttraumatic stress symptomatology after SOT is still
very limited. Only few studies have aimed to explore
preoperative risk factors of PTSS after transplantation.
We therefore examined variables such as type of trans-
plantation, history of retransplantation, preexisting psy-
chiatric morbidity, preoperative chronic benzodiazepine
consumption, preoperative alcohol abuse, and important
sociodemographic characteristics. Furthermore, we investi-
gated the association of PTSS, HRQOL and life satisfaction.
The trauma criterion was homogeneously defined as
SOT followed by ICU treatment.
Method
Participants and procedure
During the study period a total of 280 patients under-
went SOT at the Transplantation Center of the Klinikum
Grosshadern, Ludwig-Maximilians-University, Munich,
Germany.
Before SOT, the transplantation candidates were evalu-
ated by experienced consultation-liaison psychiatrists using
the observer-rating Transplant Evaluation Rating Scale
(TERS) [25]. 65 of these 280 patients died before study in-
clusion. 215 eligible SOT recipients were contacted in a
letter and were asked to complete a research battery, which
included an author-compiled clinical questionnaire, the
PTSS-10 [26,27], the Medical Outcome Study Form (SF-
36) [28] and the life satisfaction questionnaire “Fragebogen
zur Lebenszufriedenheit” (FLZ) [29]. 126 transplantation
recipients returned the questionnaires, at a mean of 24.9
months (SD=11.9) after transplantation. 84 patients re-
sponded to our letter but refused to join the study and 5
patients were untraceable. Respondents with complete data
were similar on the sociodemographic and treatment pa-
rameters to those lost due to refusal or untraceability.
Independent of type of transplantation the data ana-
lysis was performed for the whole sample according to
the homogeneously definition of the trauma criterion as
SOT followed by ICU treatment. The SF-36 data were
compared with data from normative population whose
individuals were drawn with respect to age and gender
in a pairwise matching from a large data base (n=3000)
used for the validation of the SF-36 in Germany.The study was approved by the Institutional Review
Board of the Ludwig-Maximilians-University of Munich.
Data protection met the standards set by German law.
Psychiatric history
The psychiatric history is based on a psychiatric clinical
interview before transplantation performed by experi-
enced consultation-liaison psychiatrists (H.-B. R., T. K.).
Questionnaires
Transplant Evaluation Rating Scale (TERS)
The TERS scale classifies the level of adjustment in psycho-
social functioning among SOT candidates and covers the
different dimensions of psychosocial functions (preexisting
psychiatric morbidity [e.g. PTSS, PTSD], substance abuse,
compliance, coping strategies, cognitive performance) [25].
Sociodemographic and transplantation characteristics
questionnaire
After SOT, an author-compiled questionnaire was used to
obtain information about the sociodemographic and trans-
plantation characteristics. Demographic variables included
age, gender, years of education and/or vocational training,
employment and marital status at the time of psychiatric
assessment. The patients’ employment status was catego-
rized as paid work (full- or part-time) or no paid work
(disability, retired, unemployed). Marital status was catego-
rized as married, single, divorced, or widowed. Further, a
preexisting psychiatric morbidity before SOT, pre- and
postoperative chronic benzodiazepine consumption and
alcohol abuse were recorded.
Collected transplantation characteristics were the in-
dications for heart transplantation (ischemic or dilated
cardiomyopathy), orthotopic liver transplantation (alco-
holic liver disease, infectious hepatitis, primary biliary
cirrhosis, malignancy or other), and lung transplantation
(emphysema and chronic obstructive pulmonary disease,
pulmonary fibrosis, pulmonary hypertension or other).
Postoperative medical complications, acute rejections
and a history of retransplantation were observed.
Psychometric tests
PTSS 10 [26,27]: The PTSS-10 is a self-rating 10-item
scale based on the Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV-TR), that measures the pres-
ence and intensity of posttraumatic stress symptoms. The
German version of the PTSS-10 (range: 10–70 points) has
been successfully validated in patients with PTSD after
prolonged ICU treatment and posttransplant, and has been
proved to be a reliable scale. The questionnaire shows a
high internal consistency (Cronbach’s alpha=0.93), and a
high test-retest reliability (intraclass correlation coefficient
alpha=0.89). The criterion validity was demonstrated by
ROC curve analyses resulting in a sensitivity of 77.0% and
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cant PTSS is 35 points [26,27].
SF-36 [28]: To assess HRQOL, we applied the psycho-
metrically well-validated German translation of the Med-
ical Outcome Study Form SF-36, a 36-item self-rating
questionnaire that covers eight health-related domains.
The domains are: Physical Functioning, Role Physical,
Pain, General Health, Vitality, Social Functioning, Role
Emotional, and Mental Health.
Each domain yields a score ranging from 0 to 100
(best). In the vast majority of the published studies, the
internal-consistency data of the SF-36 exceed 0.8 [28].
“Fragebogen zur Lebenszufriedenheit” (FLZ) [29]:
The FLZ is a widely used and psychometrically well-
validated self-rating life satisfaction questionnaire that
covers ten life satisfaction domains: health, occupation/
work, income/financial security, leisure time/hobbies, part-
ner relationship, family life/children, character/own skills,
sexuality, friends/acquaintances and housing/living condi-
tions. Each of the ten domains covers seven items that are
rated on a seven-point scale (ranging from “very unsatis-
fied” to “very satisfied”). In addition to gathering data on
domain-specific life satisfaction, the FLZ also allows for an
evaluation of general life satisfaction. This is calculated as
the sum total of seven of ten domains (the domains occu-
pation/work, partner relationship and family life/children
are not included). The internal-consistency data of the
FLZ are between 0.82 and 0.95 [29].
Statistical analyses
Descriptive statistics were produced based on demo-
graphic, treatment-related and psychometric data (PTSS-
10, SF-36, FLZ) and are presented as mean and standard
deviation (SD). We applied the non-parametric χ2 - test,
the Fisher’s exact test and the Mann–Whitney-U test to
test differences between patients with or without PTSS and
the non-parametric Wilcoxon signed-rank test to compare
solid-organ transplantation recipients with healthy con-
trols matched by age and gender. All statistic tests were
two-tailed, with significance set at p<0.05. In case of mul-
tiple comparisons (SF-36, FLZ), an alpha adjustment
(Bonferroni) was used. By means of multivariate analyses
in the form of multiple regression models, the level of in-
fluence by the identified risk factors and PTSS-associated
manifestation in the SF-36 and FLZ dimensions in regard
to a PTSS symptomatology was examined.
All statistical analyses were performed with IBM SPSS
Statistics 20.0 for Windows.
Results
Sociodemographic characteristics, clinical characteristics
and preoperative psychiatric morbidity
All 126 participants (69.0% men, 31.0% women) were
Caucasian, and the mean age was 52.4 (SD=11.6) years.Preoperative psychiatric diagnoses based on the TERS
and an examination by experienced consultation-liaison
psychiatrists were recorded more frequently in patients
with liver transplantation compared with patients after
heart or lung transplantation (χ2 =53.657; df=34; p=0.017).
Main preoperative psychiatric diagnoses in the subgroup of
patients with liver transplantation were substance abuse
(n=9), personality disorder [narcissistic or histrionic] (n=6),
and adjustment disorder (n=3).
Respondents with complete data were similar to those
lost due to refusal and untracebility on the sociodemo-
graphic and treatment parameters.
Table 1. summarizes the pre-transplantation clinical char-
acteristics of the whole sample, including the type of
transplantation.
Table 2. shows the sociodemographic characteristics of
the whole sample, including the type of transplantation.Posttraumatic Stress Symptoms (PTSS)
Before SOT, the psychometric observer-rating scale TERS
together with an examination by experienced consultation-
liaison psychiatrists was performed on all SOT candidates,
and in no case were preoperative posttraumatic stress dis-
order (PTSD) or PTSS diagnosed.
After the surgical intervention 19 (15.1%) SOT recipients
had clinical significant PTSS as measured on the PTSS-10
scale. The mean PTSS-10 score for the SOT recipients with
PTSS was 44.6 (SD=6.9) points and for those without PTSS
18.9 (SD=6.8) points (Mann–Whitney-U=0.0; p<0.001).
The average length of time since transplantation at the
investigation point was similar in SOT recipients with and
without clinically significant PTSS (SOT-recipients with
PTSS 28.58 months; SOT-recipients without PTSS: 24.22
months; Mann–Whitney-U: 801.5, p=0.142).Preoperative variables with an influence on the risk
of PTSS
Seven (43.8%) SOT recipients with PTSS and 12 (10.9%)
patients without PTSS had a preoperative psychiatric diag-
nosis before SOT (χ2 =11. 765; df=1, p=0.001), suggesting
an increased number of previous psychiatric illness in
SOT recipients with PTSS. Frequent preoperative psychi-
atric diagnoses in the subgroup of SOT recipients with
PTSS were adjustment disorder (n=5), alcohol depend-
ence (n=2), histrionic personality disorder (n=2), dystymia
(n=1), somatoform disorder (n=1)), obsessive compulsive
disorder (n=1) and drug abuse (n=1).
SOT recipients with PTSS more frequently take ben-
zodiazepines after the surgical intervention, but it needs
to mentioned that even before the SOT, patients with
postoperative PTSS had a higher level of benzodiaze-
pines consumption (Fisher’s exact test, p=0.018). No dif-
ferences between patients with PTSS and those without
Table 1 Pretransplantation clinical characteristics of patients
Category Heart Liver Lung/heart and lung
(n=62) (n=43) (n=21)
Indication for transplant Ischemic cardiomyopathy Alcoholic liver disease Emphysema/COPD
34 (54.8%) 13 (30.2%) 6 (28.6%)
Dilatative cardiomyopathy Infectious hepatitisa Pulmonary fibrosis
28 (45.2%) 13 (30.2%) 7 (33.3%)
Primary biliary cirrhosis Pulmonary hypertension
5 (11.6%) 3 (14.3%)
Malignancyb Otherd
6 (14.0%) 5 (23.8%)
Miscellaneousc
6 (14.0%)
a Infectious hepatitis encompasses HBV-related and/or HCV-related liver diseases.
b Malignancy includes hepatocellular carcinoma and other hepatic malignancies.
c Miscellaneous comprises Wilson’s disease, Budd-Chiari syndrome, fulminant hepatic failure, and cryptogenic cirrhosis.
d Other indications for lung transplant include lymphangioleiomyomatosis, cystic fibrosis, congenital cystic adenomatoid malformation of the lung.
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alcohol abuse (Fisher’s exact test, p=1.000).
Table 3. Pre- and postoperative frequency of benzodi-
azepine consumption and alcohol abuse.
Six liver transplant and one lung transplant recipients
had a history of retransplantation and SOT recipients with
a history of retransplantation suffered by trend moreTable 2 Sociodemographic characteristics
Category All patients H
(n = 126) (n
Gender
Male 87 (69.0%) 51
Female 39 (31.0%) 11
Age
Mean (years) 52.40 54
SD ±11.64 ±
Marital status
Single 13 (10.3%) 6
Married 95 (75.4%) 50
Widowed 2 (1.6%) 1
Divorced 16 (12.7%) 5
Employment status
Full-time 26 (20.6%) 12
Part-time/homeworker 13 (10.3%) 5
Unemployment 4 (3.2%) 3
Retired 12 (9.5%) 9
Disabled from work due to health-related resasons 71 (56.3%) 33
SD Standard deviation.
a χ2 tests.
b Kruskal-Wallis one-way analysis of variance or ranks.
C Fisher’s exact test.frequently from PTSS than those without (Fisher’s exact
test, p=0.069).
Table 4. presents the history of retransplantations of
SOT recipients with and without posttraumatic stress
syndromes.
No significant differences between SOT recipients with
PTSS and those without were found on the followingeart Liver Lung/heart and lung p
= 62) (n = 43) (n = 21)
(82.3%) 29 (67.4%) 7 (33.3%) χ2=17.648; df=2;
(17.7%) 14 (32.6%) 14 (66.7%) p<0.001a
.39 50.98 49.48 p=0.066b
11.57 ±11.72 ±11.18
(9.7%) 2 (4.7%) 5 (23.8%) p=0.163c
(80.6%) 32 (74.4%) 13 (61.9%)
(1.6%) 1 (2.3%) -
(8.1%) 8 (18.6%) 3 (14.3%)
(19.4%) 13 (30.2%) 1 (4.8%) p=0.011c
(8.1%) 8 (18.6%) -
(4.8%) 1 (2.3%) -
(14.5%) 2 (4.7%) 1 (4.8%)
(53.2%) 19 (44.2%) 19 (90.5%)





n % n % p
Alcohol No alcohol abuse before and after SOT 15 78.9 81 75.7 p=1.000a
Alcohol abuse before SOT 3 15.8 21 19.6
Current alcohol abuse after SOT 1 5.3 5 4.7
Benzodiazepines No benzo-diazepine consumption before and after SOT 12 63.2 92 86 p=0.018a
Benzodiazepine consumption before SOT 3 15.8 3 2.8
Present benzo-diazepine consumption after SOT 4 21.1 12 11.2%
PTSS postoperative posttraumatic stress symptoms.
SOT solid-organ transplantation.
a Fisher’s exact test.
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p=0.594), marital status (Fisher’s exact test, p=0.555), years
in education and/or vocational training (Mann–Whitney-
U=988.5; p=0.846) and employment status (Fisher’s exact
test, p=0.092).
SOT recipients with PTSS were younger than those
without (mean age of transplantation recipients with
PTSS 48.8 years [SD=10.1]; mean age of transplantation
recipients without PTSS 53.0 years [SD=11.8]; Mann–
Whitney-U=719.0; p=0.042).
Posttraumatic stress symptoms and type of
transplantation
Patients with liver transplantation displayed a higher level
of PTSS after the surgical intervention than patients with
heart or lung transplantation (Fisher’s exact test, p=0.003).
Table 5. illustrates PTSS according to type of trans-
plantation.
Posttraumatic stress symptoms and postoperative
medical complications
The occurrence (χ2 =1.178; df=2, p=0.585) and the num-
ber (Fisher’s exact test; p=0.933) of postoperative medical
complication (e.g. bleeding, infections, cardio-vascular)
did not significantly differ in the liver transplantation
recipients in our study from that in heart and lungTable 4 The history of retransplantations of SOT recipients w
No retransplantation
n %
SOT recipients with postoperative PTSS 16 84.2
SOT recipients without post-operative PTSS 103 96.3
PTSS postoperative posttraumatic stress symptoms.
SOT solid-organ transplantation.
a Fisher’s exact test.
b Six liver transplant and one lung transplant recipients had a history of retransplantransplantation recipients with the exception that liver
and lung transplantation recipients had significantly more
frequently acute rejections (χ2 =9.401; df=2, p=0.009). Fur-
thermore, the incidence of posttraumatic stress symptoms
after transplantation was independent of postoperative
medical complications (χ2 =0.676; df=1, p=0.462).
Health-related Quality of Life (HRQOL)
In comparison with those SOT recipients without PTSS,
transplantation recipients suffering from PTSS displayed
significant impairments in all HRQOL SF-36 domains:
Physical Functioning, Role Physical, Pain, General Health,
Vitality, Social Functioning, Role Emotional, and Mental
Health.
Table 6. shows the HRQOL SF-36 domains according
to PTSS.
As mentioned above, SOT recipients without PTSS have
significant lower impairments in all HRQOL domains than
those with PTSS. However, compared with healthy controls
matched by age and gender, even SOT recipients without
PTSS have impairments in some HRQOL SF-36 domains:
Physical Functioning (Wilcoxon-Z=−7.434, p<0.001), Role
Physical
(Wilcoxon-Z=−6.452, p<0.001), Pain (Wilcoxon-Z=−
5.075, p<0.001), General Health (Wilcoxon-Z=−4.434,




[One retransplantation: 2 (10.5%),
Two retransplantations: 1 (5.3)]
4 (3.7%) 3.7
[One retransplantation: 4 (3.7%),
Two retransplantations: 0 (0%)]
tation.
Table 5 Posttraumatic stress symptomatology according to type of transplantation
Liver transplantation Heart transplantation Lung transplantation p
n % n % n %
SOT recipients with post-operative PTSS 13 30.2% 4 6.5% 2 9.5% p=0.003a
SOT recipients without postoperative PTSS 30 69.8% 58 93.5% 19 90.5%
PTSS postoperative posttraumatic stress symptoms.
a Fisher’s exact test.
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Emotional (Wilcoxon-Z=−3.225, p=0.001).
Life satisfaction
In comparison with those SOT recipients without PTSS,
transplantation recipients showing PTSS displayed sig-
nificant impairments in the life satisfaction questionnaire
(FLZ) global score and in the life satisfaction domains
health and character/own skills.
Table 7. shows the life satisfaction domains (FLZ) ac-
cording to PTSS.
Multivariate analyses
In the univariat analyses described so far the following
risk factors for the display of PTSS after SOT were iden-
tified: 1.) preexisting psychiatric morbidity, 2.) history of
retransplantation (with the limitation that in our sample
only patients with liver or lung transplantations had
retransplantations in the past), 3.) chronic benzodiazep-
ine consumption, 4.) age, and 5.) type of transplantation.
In the second step a multivariate analysis in the form of
a multiple-regression model was used to examine the
levels of influence of the identified risk factors of PTSS.
The following predictors were selected in the prediction
of PTSS-10 values: preexisting psychiatric morbidity,
history of retransplantation, benzodiazepine consump-
tion before transplantation, age, and type of transplant-
ation. Added to the list of predictors were medical
complications, survival time since transplantation andTable 6 HRQOL SF-36 domains according to posttraumatic str
SOT recipients with postoperative PTSS SOT re
(n=19) (n=10
Mean SD Mean
Physical functioning 40.3 ±26.0 68.8
Role physical 25.0 ±39.1 57.7
Pain 34.8 ±23.9 69.1
General health 31.2 ±17.8 61.2
Vitality 31.3 ±17.9 57.8
Social functioning 53.3 ±23.5 85.0
Role emotional 35.1 ±45.1 81.7
Mental health 41.7 ±18.4 78.7
PTSS posttraumatic stress symptoms.
SOT solid-organ transplantation.
a Mann–Whitney-U-test; alpha adjustment (Bonferroni): p<0.006.gender. This model yields a R2 (adj.) =0.145, F=3.125,
p=0.002 and shows that significant predictors of PTSS
post-SOT are preexisting psychiatric morbidity and his-
tory of retransplantation.
In a third step, an additional multiple regression model
was calculated that included the PTSS-associated dimen-
sions in HRQOL (SF-36) and life satisfaction (FLZ) iden-
tified in the univariat analyses as well as benzodiazepine
consumption after SOT. This model yields R2 (adj.) =
0.562, F=37.229, p<0.001 and shows the statistically sig-
nificant associative relationship between impaired
HRQOL (SF-36 - physical health subscales: p<0.001; SF-
36 mental health subscales p<0.001) and life satisfaction
(FLZ - occupation, work: p=0.004) and PTSS-10 values.
Table 8. Multiple regression analyses.
Discussion
Although the standardizations of surgical procedures
and improvements in intensive care treatment, patient
selection, tissue matching and organ preservation have
advanced the success of SOTs, PTSS remain a frequent
finding in post-SOT patients, and until now only few em-
pirical data exist about the prevalence of PTSS among pa-
tients undergoing SOTs [30,31]. PTSS after SOT can cause
compliance problems and decreases long-term survival
[32]. In our study 19 (15.1%) SOT recipients displayed
PTSS. This rate is consistent with previous research. For
example, in an orthotopic liver transplantation study by
Rothenhäusler et al. [24], 2.7% suffered from full PTSDess symptomatology











Table 7 Life satisfaction domains (FLZ) according to PTSS
SOT recipients with PTSS SOT recipients without PTSS
Mean SD Mean SD Mann–Whitney-U p
FLZ Global Score 241.0 ±29.8 274.4 ±29.2 228.0 p=0.002a
Health 23.2 ±9.7 38.4 ±7.0 174.0 p<0.001a
Occupation/work 28.6 ±16.4 39.0 ±6.8 407.0 p=0.028a
Income/financial security 27.9 ±13.0 37.0 ±8.3 467.0 p=0.013a
Leisure time/hobbies 34.1 ±11.2 40.1 ±6.8 548.0 p=0.036a
Partner relationship 37.3 ±12.4 43.2 ±7.1 395.0 p=0.039a
Family life/children 38.2 ±13.4 40.7 ±7.7 407.5 p=0.839a
Character/own skills 34.8 ±7.4 40.8 ±3.8 401.5 p=0.001a
Sexuality 33.1 ±11.5 35.2 ±8.5 518.5 p=0.538a
Friends/acquaintances 34.3 ±8.3 39.0 ±5.3 544.5 p=0.029a
Housing/living conditions 39.4 ±5.5 42.6 ±4.7 529.0 p=0.021a
PTSS posttraumatic stress symptoms.
SOT solid-organ transplantation.
a Mann–Whitney-U-test; alpha adjustment (Bonferroni): p<0.005.
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In another study by Favaro et al. [33], the estimated fre-
quency of transplantation-related PTSS after heart trans-
plantation was 12%. PTSD in SOT recipients may indicate
a failure of the patient to come to terms with the transplant
experience and Dew et al. reported that the risk of mortal-
ity increases in patients who met criteria for postraumatic
stress disorder after heart transplantation [16,34]. Little is
known about predictors and risk factors of posttraumatic
stress symptomatology after SOT. Favaro et al. [33] de-
scribe a preoperative history of depressive episodes andTable 8 Multiple regression analyses
Model R
Model 1: risk factors for PTSS 0.461
Model 2: PTSS associated dimensions








Type of transplantation - liver
Type of transplantation - lung
Medical complications
Survival time since transplanta
Model 2: SF-36: physical health
SF-36: mental health
FLZ – occupation/work
Benzodiazepine consumption aperceived social support as risk factors of postoperative
posttraumatic stress symptomatology.
Dew et al. [16,34-36] evaluated in a longitudinal study
risk factors for posttraumatic stress disorder related to
transplantation during the first year after heart transplant-
ation. The following pre-transplant and perioperative risk
factors increased recipients’ risk of any psychiatric dis-
order: pre-transplant psychiatric history, poor social sup-
port, the use of avoidance coping strategies for managing
health problems, and low self esteem early posttransplant.
Regarding PTSD, the waiting period for transplantR2 R2 (adj.) F p
0.213 0.145 3.125 0.002




ity 6.505 3.067 0.036
11.586 4.836 0.018








fter transplantation 2.255 0.070 0.279
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SOT recipients.
In analysing the data of our study we identified the fol-
lowing additional preoperative risk factors for developing
postoperative PTSS symptomatology after SOT: 1.) a his-
tory of liver or lung retransplantation, 2.) preoperative
chronic benzodiazepine consumption, 3.) age, and 4.) type
of transplantation. Dew et al. [34] previously have reported,
that a pre-existing psychiatric morbidity is a preoperative
risk factor for developing postoperative PTSS symptomatol-
ogy. Our study also confirms this finding. In comparison
with heart or lung transplantation recipients, the subgroup
of liver transplantation recipients observed in this study
had greater preoperative psychiatric comorbidity and a
higher risk for developing PTSS after the transplantation.
A multiple regression analysis identified a preexisting
psychiatric morbidity and a history of retransplantation
as significant predictors of PTSS in SOT recipients. The
occurrence of postoperative medical complications (e.g.
bleeding, infections, cardio-vascular, rejection) did not sig-
nificantly differ in SOT patients with postoperative PTSS
from those without PTSS.
HRQOL and life satisfaction are an important measure
of outcome after SOT [11,30], and in recent years, severalFigure 1 Posttraumatic stress symptoms (PTSS) after solid-organ tran
quality of life and life satisfaction. 1 univariat testing significant; 2 multipstudies have demonstrated that SOT has beneficial effects
on the health-related quality of life for the majority of pa-
tients, both in intermediate and in long-term outcomes
[24]. In addition, Goetzmann et al. [37] showed in a pro-
spective study among SOT recipients that an organ trans-
plant significantly improved posttransplant life satisfaction
[37]. Dew et al. [38] found, that emotional well-being was
stable or improved in the first 12 months after heart trans-
plantation and in addition the physical functional status on
standard functional measures of sleep, body care, mobility
and ambulation improved in the same period significant.
In this present study even SOT recipients without PTSS
displayed more impairments in some HRQOL domains
than healthy controls matched by age and gender. It is
recognised that PTSS impairs HRQOL and life satisfaction
in people with overall good health. Therefore a major aim
of the present study was to explore the associations be-
tween impairments in HRQOL and life satisfaction of
transplant patients suffering from concomitant PTSS. The
SOT recipients with PTSS examined in this study had a
lower HRQOL compared with patients without PTSS and
impairments in the following HRQOL SF-36 domains
were found: Physical Functioning, Role Physical, Pain, and
General Health in the physical health SF-36 subscales, andsplantation (SOT) - risk factors and the impact on health-related
le regression.
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Health in the mental health SF-36 subscales.
Furthermore the life satisfaction domains (FLZ) Health
and Character/Own Skills were affected. In addition a
multivariate analysis showed the statistically significant
associative relationship between impaired HRQOL (SF-36
physical health subscales, SF-36 mental health subscales),
life satisfaction (occupation, work) and PTSS-10 values.
In conclusion our results suggest that PTSS are strongly
associated with massive additional impairments of HRQOL
and life satisfaction in SOT recipients.
Figure 1. PTSS after solid-organ transplantation (SOT) -
risk factors and the impact on health-related quality of life
and life satisfaction.
Limitations
Finally, there are several limitations to this study that de-
serve mention. The format of the study is a retrospective
follow-up, and the absence of a prospective randomized
trial makes it difficult to definitively conclude that the
HRQOL associations observed are causal in nature.
The response rate is similar to that reached in other
comparable studies (e.g. Rothenhäusler et al. [24]). As the
eligible SOT recipients were asked in a letter, not in a face-
to-face follow-up check, to participate in this study reasons
for refusal could not be collected in all patients. A possible
skewing of the study results due to the response rate of
59% cannot definitely be ruled out. The PTSS-10 is not
sufficient for the diagnosis of posttraumatic stress disorder.
Therefore elevated PTSS-10 scores were only classified as
posttraumatic stress symptoms. Pre-transplant psycho-
social assessments might be distorted due to the point,
that SOT candidates are concerned that any informa-
tion that they impart could influence the transplant team’s
decisions about the patient’s candidacy. Furthermore, the
study population consists of a mixed group of patients
with different organ entities, in whom transplantation has
been conducted and the small group size of the organ-
subgroups is a limitation to differ between the different
subgroups. However, in regard to posttraumatic stress
symptoms common data interpretation is possible due to
the homogeneously trauma criterion definition as SOT
followed by ICU treatment. Finally, preoperative psychi-
atric diagnoses based on the TERS and an examination by
consultation-liaison psychiatrists. Additional structured in-
terviews have not been conducted to secure the diagnoses.
Conclusions
SOT recipients may face major transplantation- and
treatment-related PTSS and impairments to their HRQOL
and life satisfaction. Much speaks in favour of searches for
preoperative risk factors that might help to predict post-
operative PTSS. Advance warning of the threats of this
condition could potentially reduce significant morbidity,mortality, and compliance problems. Further, PTSS are
highly associated with impairments to patients’ overall
quality of life and life satisfaction. In conclusion we advise
that as part of routine clinical care, an early and compre-
hensive bio- and psychosocial diagnosis and therapeutic
treatment of SOT patients to be carried out, so that their
posttraumatic stress symptomatology can be treated rap-
idly and their quality of life and life satisfaction can be
improved.
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